BioNexus Gene Lab Corp.
BGLC
Rank in Stocks
#32058
BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala... BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia. These essential chemicals are utilized in the manufacturing of a wide array of products, including handrails, bench tops, components for the automotive and aerospace industries, cleanroom panels, and various instruments. Additionally, through its other subsidiary, BioNexus Gene Lab Sdn. Bhd., the company is involved in the development and provision of non-invasive liquid biopsy tests, designed for the early detection of biomarkers.
Share Price
$0.8589
Last synced: 2026-11-11
Market Cap
$2.08M
Change (1 day)
4.74%
Change (1 year)
-81.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade BioNexus Gene Lab Corp. (BGLC)
Category
Industrials
EPS for BioNexus Gene Lab Corp. (BGLC)
EPS as of June 2026 TTM: $-1.26
According to BioNexus Gene Lab Corp.'s latest financial reports, its current EPS (TTM) is $-1.26. At the end of 2025 the company had an EPS of $-1.61, a decrease compared to its 2024 EPS of $-0.90.
EPS history for BioNexus Gene Lab Corp. from 2016 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-1.26 | -21.74% |
| 2025 | $-1.61 | 78.89% |
| 2024 | $-0.90 | -41.18% |
| 2023 | $-1.53 | 512.00% |
| 2022 | $-0.25 | -147.17% |
| 2021 | $0.53 | -58.59% |
| 2020 | $1.28 | -3,842.69% |
| 2019 | $-0.03 | -812.50% |
| 2018 | 0.00 | -124.12% |
| 2017 | $-0.02 | 19,800.00% |
| 2016 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $45.57 | -3,716.67% |
US
|
|
| $1.24 | -198.41% |
US
|
|
| $10.47 | -930.95% |
US
|
|
| $16.23 | -1,388.10% |
US
|
|
| $-0.83 | -34.13% |
US
|
Questions about BioNexus Gene Lab Corp.'s earnings per share (EPS)
What is BioNexus Gene Lab Corp.'s earnings per share (EPS)?
BioNexus Gene Lab Corp.'s earnings per share (EPS) over the last twelve months is $-1.26, as of Jun 2026.
What was BioNexus Gene Lab Corp.'s earnings per share (EPS) in 2025?
In 2025, BioNexus Gene Lab Corp.'s earnings per share (EPS) was $-1.61, compared with $-0.90 in 2024.
How has BioNexus Gene Lab Corp.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, BioNexus Gene Lab Corp.'s earnings per share (EPS) was highest in 2020 ($1.28) and lowest in 2025 ($-1.61).
How does BioNexus Gene Lab Corp.'s earnings per share (EPS) compare with similar companies?
BioNexus Gene Lab Corp.'s earnings per share (EPS) ($-1.26) is lower than that of all 5 similar companies listed above. The highest among them is W.W. Grainger, Inc., with $45.57.